pharmaceutical
Google Cloud Announces AI Partnerships with PathAI and TetraScience
Google’s latest developments in AI have left the community wanting more. The rollout to Gemini came with image generation issues that CEO Sundar Pichai called “completely unacceptable”. However, the ...Full Article
Insilico, Pfizer Join AI Forces on Drug Discovery
Previous attempts to apply AI to drug discovery have yielded mixed results. For example, IBM ended sales last year of its Watson AI software used by pharmaceutical firms for ...Full Article
Drug Developers Enlist Google Cloud HPC in the Fight Against ALS
Within the haystack of a lethal disease such as ALS (amyotrophic lateral sclerosis / Lou Gehrig's Disease) there exists, somewhere, the molecular needle that will pierce this therapy-resistant affliction. ...Full Article
UK Using Cognitive Computing in Personalized Medicine Push
As the pharmaceutical industry moves from the era of “blockbuster” drug discovery (developing a single drug that targets large numbers of people with a particular disease) to the era ...Full Article
Case Study: Bringing the Power of HPC to Drug Discovery and the Delivery of ‘Smarter’ Healthcare
As recently as eight years ago, the application of high performance computing (HPC) techniques to drug discovery efforts was problematic at best. Even clusters composed of 40 or 50 ...Full Article
